Guidance and quality standards Awaiting development
Showing 311 to 314 of 314
Title | Type |
---|---|
Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments [ID6416] | Technology appraisal guidance |
Zavegepant for treating acute migraine TSID 11998 | Technology appraisal guidance |
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer TSID 12040 | Technology appraisal guidance |
Zuranolone for treating severe postnatal depression ID6431 | Technology appraisal guidance |